Form 4 for TDOC Teladoc Health, Inc.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-11-29 · accession 0001628280-24-049800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-03 | 2024-11-29 | TDOC | Nueno Carlos | Pres, International | M - OptEx | — | +5,279 | 5,279 | New | — |
| DM | 2024-12-03 | 2024-12-02+ | TDOC | Nueno Carlos | Pres, International | S - Sale+OE | $11.55 | -5,279 | 0 | -100% | -$61.0K |
| DM | 2024-12-03 | 2024-11-29 | TDOC | Nueno Carlos | Pres, International | M - OptEx | $0.00 | -5,279 | 1,123 | -82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-29 | M | A | 1,056 | — | 1,056 | D | — | — | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-11-29 | M | A | 1,123 | — | 2,179 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis |
| 3 | Common | Common Stock | 2024-11-29 | M | A | 3,100 | — | 5,279 | D | — | — | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis |
| 4 | Common | Common Stock | 2024-12-02 | S | D | 2,389 | $11.93 | 2,890 | D | — | — | (F3) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| 5 | Common | Common Stock | 2024-12-03 | S | D | 2,890 | $11.23 | 0 | D | — | — | (F4) This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 6, 2023. |
| 6 | Derivative | Restricted Stock Units | 2024-11-29 | M | D | 3,100 | $0.00 | 15,502 | D | — · — to — | 3,100 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis (F7) On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 7 | Derivative | Performance Stock Units | 2024-11-29 | M | D | 1,056 | $0.00 | 5,285 | D | — · — to — | 1,056 Common Stock | (F1) Performance stock units convert to shares of TDOC common stock on a one-for-one basis. (F5) On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 8 | Derivative | Restricted Stock Units | 2024-11-29 | M | D | 1,123 | $0.00 | 1,123 | D | — · — to — | 1,123 Common Stock | (F2) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis (F6) On March 1, 2022, the reporting person was granted 13,475 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |